Market Tracker

02/12 5:16pm ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

4.01
Delayed Data
As of Feb 12
 -0.06 / -1.47%
Today’s Change
3.61
Today|||52-Week Range
11.15
-34.58%
Year-to-Date
No recent news for Progenics Pharmaceuticals Inc.

Today’s Trading

Previous close4.07
Today’s open4.13
Day’s range3.91 - 4.13
Volume1,392,858
Average volume (3 months)993,600
Market cap$279.9M
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-1,091.67%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)+464.45%
P/E ratioNM
Price/Sales11.63
Price/Book2.24

Competitors

 Today’s
change
Today’s
% change
OMEDOncoMed Pharmaceutic...+0.16+1.77%
AKBAAkebia Therapeutics ...+0.45+6.22%
INFIInfinity Pharmaceuti...+0.36+6.47%
----
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateMarch 14, 2016
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$44.4M
Annual profit (last year)$4.4M
Net profit margin9.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark Robert Baker
Chief Financial Officer &
Senior Vice President
Patrick Fabbio
Corporate headquarters
Tarrytown, New York

Forecasts